CARIS LIFE SCIENCES, INC. Basic Shares Outstanding (Weighted Average)
CARIS LIFE SCIENCES, INC. (CAI) reported Basic Shares Outstanding (Weighted Average) of 282.89 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 282.89M shares, a 335.76% increase year-over-year.
- CARIS LIFE SCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 282.56M shares, a 693.20% increase year-over-year.
- CARIS LIFE SCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 283.48M shares, a 694.98% increase year-over-year.
- CARIS LIFE SCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 282.10M shares, a 691.44% increase year-over-year.
- CARIS LIFE SCIENCES, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 167.21M shares, a 371.04% increase from fiscal 2024.
- CARIS LIFE SCIENCES, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 35.50M shares, a 1.59% increase from fiscal 2023.
- CARIS LIFE SCIENCES, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 34.94M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 282.89M shares 10-Q · filed 2026-08-05 | 282.73M shares 10-Q · filed 2026-08-05 | 282.98M shares derived: average of 3 quarters · filed 2026-08-05 | 282.76M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 282.56M shares 10-Q · filed 2026-05-08 | 283.02M shares derived: average of 2 quarters · filed 2026-05-08 | 282.71M shares derived: average of 3 quarters · filed 2026-05-08 | 228.26M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 283.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 282.79M shares derived: average of 2 quarters · filed 2026-03-03 | 210.17M shares derived: average of 3 quarters · filed 2026-08-05 | 167.21M shares 10-K · filed 2026-03-03 |
| 2025-09-30 | 282.10M shares 10-Q · filed 2025-11-05 | 173.51M shares derived: average of 2 quarters · filed 2026-08-05 | 128.45M shares 10-Q · filed 2025-11-05 | 104.57M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 64.92M shares 10-Q · filed 2026-08-05 | 50.35M shares 10-Q · filed 2026-08-05 | 45.40M shares derived: average of 3 quarters · filed 2026-08-05 | 42.96M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 35.62M shares 10-Q · filed 2026-05-08 | 35.64M shares derived: average of 2 quarters · filed 2026-05-08 | 35.64M shares derived: average of 3 quarters · filed 2026-05-08 | 35.57M shares derived: average of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | 35.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 35.65M shares derived: average of 2 quarters · filed 2026-03-03 | 35.56M shares derived: average of 3 quarters · filed 2026-03-03 | 35.50M shares 10-K · filed 2026-03-03 |
| 2024-09-30 | 35.64M shares 10-Q · filed 2025-11-05 | 35.51M shares derived: average of 2 quarters · filed 2025-11-05 | 35.44M shares 10-Q · filed 2025-11-05 | |
| 2024-06-30 | 35.37M shares 10-Q · filed 2025-08-12 | 35.34M shares 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | 34.94M shares 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |